Cochrane Abstracts
Long‐acting beta2‐agonists for chronic obstructive pulmonary disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Long‐acting Beta2‐agonists for Chronic Obstructive Pulmonary Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432362/all/Long‐acting_beta2‐agonists_for_chronic_obstructive_pulmonary_disease.
Long‐acting beta2‐agonists for chronic obstructive pulmonary disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432362/all/Long‐acting_beta2‐agonists_for_chronic_obstructive_pulmonary_disease. Accessed January 24, 2026.
Long‐acting beta2‐agonists for chronic obstructive pulmonary disease. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432362/all/Long‐acting_beta2‐agonists_for_chronic_obstructive_pulmonary_disease
Long‐acting Beta2‐agonists for Chronic Obstructive Pulmonary Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432362/all/Long‐acting_beta2‐agonists_for_chronic_obstructive_pulmonary_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Long‐acting beta2‐agonists for chronic obstructive pulmonary disease
ID - 432362
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432362/all/Long‐acting_beta2‐agonists_for_chronic_obstructive_pulmonary_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
